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The human T-cell leukemia virus type-l (HTLV-1) contains a unique pX region, which encodes the gene 
products p40”, ~27~” and ~21~“‘. ~40” is required for transcriptional trans-activation, whereas ~27~~“’ and 
~21”” have no such function. Transfection of pX expression plasmids containing different combinations 
for the three gene products into cells integrated with HTLV-1 proviruses defective in pX expression revealed 
that both ~40” and ~27~~“’ are required for expression of the gag protein and accumulation of gag mRNA. 
These observations uggest hat the pX product pW activates transcription and ~27~” controls the level 
of gag mRNA by post-transcriptional modulation. 
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1. INTRODUCTION 
Human T-cell leukemia virus type 1 (HTLV-1) 
[ 1,2] is thought to be involved in leukemogenesis in
adult T-cell leukemia (ATL) [2-51. The unique pX 
region between the env and 3’LTR of HTLV-1 [6] 
codes for three proteins, ~40” [7-lo], p27*” and 
p21”” [ll], and one of these, ~40” also termed 
tat-l, was shown to be a transcriptional trans- 
activator which can activate the viral long terminal 
repeat (LTR) [ 12-181 as well as the genes for in- 
terleukin 2 (IL-2) and its receptor (IL-2R) in T cells 
[19,20]. Thus, ~40” is believed to be essential for 
efficient viral replication and induction of abnor- 
mal proliferation of infected T-lymphocytes. The 
other two gene products, ~27”” and ~21’~” are 
not required for the trans-activation of the LTR- 
CAT construction [16-181, IL-2 or IL-2R genes 
[20] and their roles have not been well elucidated 
to date. In this work, we found that ~27~” along 
with p4W is required for expression of the gag gene 
from the integrated proviral genome. 
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2. MATERIALS AND METHODS 
2.1. Transfection 
FL45 cells (6 x 10’) were seeded on 60 mm plate 
and transfected the following day with 6pg of 
plasmid DNA by the calcium phosphate method 
described [13]. After 40 h incubation, the cells 
were divided into two groups and subjected to 
either indirect immunofluorescence staining or to 
extraction of RNA and proteins. 
2.2. RNA and protein analyses 
Total cellular RNA was extracted with vanadyl 
complexes by the procedure of Berger and 
Birkenmeier [21]. The poly(A) RNA was 
denatured with 2.2 M formaldehyde, elec- 
trophoresed in 1% agarose gel, and transferred on- 
to nitrocellulose filter. RNA on the filter was 
hybridized with the 32P-labeled gag probe (see 
fig.lA) at 42°C under the conditions of 50% for- 
mamide and 0.6 M NaCl. 
Viral antigens were characterized by blot pro- 
cedure using serum from an ATL patient. 
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3. RESULTS 
Since the second and third products of the pX 
region of HTLV-1, p27*-” and p21”“, were not 
required for tram-activation of the LTR-CAT 
[ 17,181, cellular IL-2 and IL-2R genes [20], we 
tested the effect of the pX proteins on the expres- 
sion of genes in the HTLV provirus. A defective 
provirus genome HTLVoaopx was constructed by 
a deletion of the sequence between the Bg/II site 
located at the 5 ’ -region of pal and the BarnHI site 
at the 3’-region of env of the XATK-1 clone 
(fig. 1A) [6]. This defective provirus, HTLV~AGP~, 
has the capacity to produce the gag proteins and 
AATK-1 
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PM-rCXdb 
pMTCXds-ATG164 
PMTCXSS 
Fig. 1. Schematic illustration of HTLV-1 proviruses, 
hATK-1 and GAGPX (A), and of plasmids for pX 
expression (B). (A) SD. and S.A., splicing donor and 
acceptor sites; (A) initiation codons; thick horizontal 
bar represents DNA sequences used for hybridization 
probe. (B) Construction of pX plasmids. The cDNA 
sequence of pX mRNA were inserted under the 
metallothioneine promoter (MT) with various 
modifications. Details for pMTCXdb and pMTCXds- 
ATG1&4 were described in [ 181. pMTCXss has a large 
deletion from StuI (no.8033 from the 5 ‘-end of AATK-1) 
to SmaI (no.8310). (A) Initiation codons. 
the smallest pX protein p21”“, but not the two 
other major pX proteins p4oX and p27’-“’ nor pol 
and env proteins, since the initiation codons for ex- 
pression of p4v and p27”” were deleted (fig. 1A). 
HTLvo~opx DNA along with a gene conferring 
neomycin resistance was transfected into FL cells, 
a human amnion cell line, and a stable cell line 
FL45 was isolated by G418 selection. Southern 
blot analysis of FL45 DNA showed multicopy in- 
tegration of HTLvo~opx (not shown). Neither 
viral mRNA nor proteins were detected in the 
FL45 cells by Northern blot analysis, indirect im- 
munofluorescence staining or Western blot 
analysis (not shown). 
The FL45 cell line was transfected with a 
plasmid, pMTCXdb [20], containing the wild type 
coding sequence for the pX proteins, the transcrip- 
tion of which is controlled by a metallothionein 
promoter (fig.lB). After 2 days, the transfected 
cells were stained by the indirect im- 
munofluorescence method using monoclonal an- 
tibody against a gag protein ~19. Several percent 
of transfected cells were stained strongly, in- 
dicating production of gag proteins. The gag pro- 
tein expressed was characterized by Western blot 
assay. As shown in fig.ZA (lane a), a gag precursor 
Pr53 was detected in cells transfected with 
pMTCXdb. These results clearly demonstrate that 
a proviral genome defective in pX expression can 
express its gag gene when the pX functions are sup- 
plied exogenously. Transfection with a plasmid, 
pMTCXss, containing a single large deletion in the 
coding sequence for ~40” yielded no expression of 
the gag gene lending support to the conclusion that 
~40” trans-activation is required for gag ex- 
pression. 
On the other hand, a mutant plasmid 
pMTCXds-ATG1&4 [20], which can code for ~40” 
but not for p27”” and ~21”” (fig.lB), was also 
found to be unable to induce gag gene expression 
(fig.2A, lane b). Normal expression of ~40” in 
these cells was confirmed by the activation of 
pLTR-CAT and also by Western blot analysis. 
Failure of p4v alone to induce gag gene expression 
was unexpected since this gene product is capable 
of activating transcription from the viral LTR 
[16-181. To verify the requirement of 
p27X-ZZZ~p2~x-ZZZ for expression of the gag gene, a 
complementation assay was carried out: two 
plasmids, pMTCXds-ATG1&4 and pMTCXss, 
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Fig.2. Effect of p27”” expression on the levels of gag 
protein and mRNA. (A) Detection of gug gene products: 
whole cell lysate (30 pg proteins) was subjected to 12.5% 
polyacrylamide gel electrophoresis followed by blotting 
analysis using an ATL patient serum. Lysates of FL45 
cells transfected with 6 /rg of pMTCXdb (a), pMTCXds- 
ATG1&4 (b), pMTCXds-ATG1&4 plus pMTCXss (c) 
and pMTCXss (d) were analysed. Lysate of HUT102 
cells (e). (B) Detection of the gag mRNA: poly(A) RNA 
extracted from 3 x lo6 cells were analysed by the 
Northern blot procedure using the gag probe (see 
fig. 1A). RNA samples were prepared from the same cells 
as described in (A). 
which can code for ~40” and p27”“‘/p21”“, 
respectively, were cotransfected into FL45 cells. 
Expression of the gag precursor Pr53 was observed 
(fig.ZA, lane c). This result clearly indicates that 
p4oX alone is not sufficient and a second product, 
p27”” or p2 lx-zzz, is required for gag gene expres- 
sion. However, transfection of pMTCXds-ATGl 
(p4@ and ~21”“‘) could not induce the gag expres- 
sion, thus it was suggested that p27x-zzz is the re- 
quired second factor. 
To elucidate which process is modulated by 
p27”“, gag mRNA in transfected FL45 cells was 
analysed by the Northern blot procedure using the 
gag sequence as a probe. In conjunction with the 
expression of Pr53, two distinct gag mRNA species 
(5.0 and 9.7 kb) were observed in FL45 cells 
transfected with the wild type plasmid, but not in 
cells with plasmid unable to express ~27~-” (fig.2, 
lanes a and b). The 5.0 kb band corresponds to a 
transcript from the defective provirus sequence 
HTLVGAGPX, and the 9.7 kb may represent a 
transcript from tandemly integrated proviral se- 
quences. Complementation of plasmid lacking in 
expression of ~27’~” with a p27x-zzz expression 
plasmid rescued the gag mRNA (fig.2B, lane c). 
These results clearly indicate that p27*” plays a 
critical role in regulation of gag mRNA levels. No 
gag mRNA was detected without ~40” even in the 
presence of p27”” (fig.2B, lane d). 
4. DISCUSSION 
In this study, we have presented evidence that 
p27^“‘, a second pX protein of HTLV-1, is re- 
quired for expression of the gag gene and also for 
accumulation of the mRNA. From these observa- 
tions, it was concluded that p27”” affects the 
mRNA levels. For activation of transcription from 
the LTR in pLTR-CAT, cellular IL-2 or IL-2R 
genes, ~40” alone is sufficient [17,18,20]. 
However, for gag gene expression, both ~40” and 
p27“” were found to be required. Since p4oX can 
activate transcription from the LTR [12-181, even 
from the integrated form of the LTR (J.I., un- 
published), it is reasonable to assume that ~27”” 
modulates the post-transcriptional process, which 
eventually affects the gag mRNA levels. The pro- 
cess modulated by p27“” could be splicing, 
transport, or stabilization of mRNA precursors or 
the mRNA itself. A similar requirement for ~27”“’ 
was observed on other proviral constructions, thus 
it should not be an artifact of the HTLVGAGPX con- 
struction in particular (not shown). 
Post-transcriptional regulation was also 
demonstrated on HIV (HTLV III/LAV) by 
Sodroski et al. [22]. They reported, however, that 
gag and env expression were affected by the art 
gene, but that their mRNA levels were not. 
Therefore, the mode of function of ~27’~” seems 
to differ from the art of HIV. 
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